Discovery Grants support researchers conducting preliminary and proof-of-concept studies in psoriatic disease and related comorbidities to establish new programs competitive for long-term funding.
The closed 2026 cycle notice has been replaced with a 2027 application deadline of January 15, 2027, at 11:59 p.m. ET. The $75,000 annual cap now permits up to 10% indirect costs if required by your institution, replacing the direct-costs-only rule; indirect costs are not mandatory.
Early Career Research Grants support early-career investigators conducting psoriatic disease research, combining project support with career development to help them build lasting careers in the field.
Translational Research Grants support researchers moving basic discoveries into clinical applications, funding work across psoriatic disease to benefit people with psoriasis and psoriatic arthritis.
Bridge Grants support investigators with a long-term commitment to psoriatic disease research, funding work on psoriasis, psoriatic arthritis, and related comorbidities while they seek further support.
Psoriatic Disease Research Fellowships support physicians through institutional research training to advance the treatment, prevention, and cure of psoriasis, psoriatic arthritis, and related comorbidities.
Milestones to a Cure supports independent investigators pursuing bold mechanistic, clinical, and translational research to overcome scientific barriers to durable remission and a cure for psoriatic disease.